| Mrs Nicole Elise Stewart, LMLP | |
|
645 E Iron Ave, Suite C, Salina, KS 67401-2697 | |
| (785) 823-0001 | |
| (785) 914-5250 |
| Full Name | Mrs Nicole Elise Stewart |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Cognitive & Behavioral |
| Location | 645 E Iron Ave, Salina, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134425309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TB0200X | Psychologist - Cognitive & Behavioral | 1486 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nicole Elise Stewart, LMLP 645 E Iron Ave, Suite C, Salina, KS 67401-2697 Ph: (785) 823-0001 | Mrs Nicole Elise Stewart, LMLP 645 E Iron Ave, Suite C, Salina, KS 67401-2697 Ph: (785) 823-0001 |
News Archive
Lawmakers in Richmond are deep in budget negotiations and will soon decide which parts of the mental health-care system will receive a funding boost. The House and Senate proposals have a number of differences, and what emerges will likely be a mash-up of the two (Shin, 3/5).
U.S. government-issued dietary recommendations continue to evolve over time. In a special article published in Mayo Clinic Proceedings, an obesity theorist and cardiovascular health researchers claim that the main source of dietary information used by the U.S. Government's 2015 Dietary Guidelines Advisory Committee (DGAC) is scientifically flawed because the underlying data are primarily informed by memory-based dietary assessment methods (M-BMs) (eg, interviews and surveys).
Elkem Silicones, a leading fully integrated global silicone supplier with more than 60 years of formulation and manufacturing expertise, will feature its Silbione and Silbione Biomedical range of medical grade silicones at the upcoming Compamed 2019 trade fair in Düsseldorf, Germany, from November 18th -21st.
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
› Verified 7 days ago
Mr. David Alaric Winters, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1804 Glendale, Salina, KS 67401 Phone: 785-823-5006 | |
Denise Puerto, Psychologist Medicare: Medicare Enrolled Practice Location: 730 Holly Ln, Salina, KS 67401 Phone: 785-452-4948 Fax: 785-452-6119 | |
Darrin Edwin Sewell, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5097 W Cloud St, Salina, KS 67401 Phone: 785-825-0563 Fax: 785-825-0623 | |
Everett Deane Dehaven, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 | |
Vesna M Matic-wright, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 509 E Elm St, Salina, KS 67401 Phone: 785-825-0541 Fax: 785-825-4024 | |
Jeffrey Dohm, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 |